LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end stage liver disease. Other therapeutic targets for organ regeneration include the thymus, pancreas, and kidney. Privately held, LyGenesis is headquartered in Pittsburgh, Pennsylvania. To learn more, please visit our website at www.lygenesis.com.
| Website | https://www.lygenesis.com |
| Employees | 8 (5 on RocketReach) |
| Founded | 2017 |
| Address | Shady Ave, Pittsburgh, Pennsylvania 15221, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Clinical Trials, Health Care, Medical |
| Keywords | Biotechnology, Organ Regeneration, Regenerative Medicine, Biopharmaceutical, Life Sciences, Bioreactor Technology, Therapeutic Platform, Tissue Engineering, Cell Therapy, Medical Technology, Drug Development, Healthcare, Liver Regeneration, Transplantation, Patient Care, Preclinical Trials, Clinical Development |
| Competitors | MiMedx, Organogenesis, Acelity, Sangamo Therapeutics, Inc., Athersys, Tissue Regenix Group, Citius Pharmaceuticals, Inc., PROMETHERA Biosciences S.A./N.V., Histogen Inc, Avalon Globocare Corp (NASDAQ: AVCO) +33 more (view full list) |
Looking for a particular LyGenesis employee's phone or email?
Michael Hufford is the Co-Founder and CEO of LyGenesis.
5 people are employed at LyGenesis.
LyGenesis is based in Pittsburgh, Pennsylvania.